Brainsway (BWAY) Non-Current Assets (2018 - 2025)
Brainsway (BWAY) posted quarterly Non-Current Assets of $29.4 million for Q4 2025, up 100.51% year-on-year from $14.6 million in Q4 2024, and up 30.33% on a QoQ basis from $22.5 million in Q2 2025.
Brainsway (BWAY) Non-Current Assets (2018 - 2025) Analysis & Trends
Brainsway (BWAY) has reported Non-Current Assets for 8 consecutive years, with $29.4 million the latest figure, recorded in Q4 2025.
- Quarterly Non-Current Assets rose 100.51% year-over-year to $29.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $53.5 million (up 265.61% YoY) and the FY2025 annual result came in at $29.4 million, up 100.51% from the prior year.
- Non-Current Assets improved to $29.4 million in Q4 2025 per BWAY's latest filing, from $22.5 million in the prior quarter.
- Over the last five years, Non-Current Assets for BWAY reached as high as $29.4 million in Q4 2025 and fell as low as $6.4 million in Q4 2022.
- A 5-year average of $13.2 million and a median of $9.6 million in 2021 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets plunged 37.89% — and 2025, when it surged 100.51%.
- Year by year, Non-Current Assets stood at $10.3 million in 2021, then tumbled by 37.89% to $6.4 million in 2022, then rose by 17.52% to $7.5 million in 2023, then soared by 95.1% to $14.6 million in 2024, then jumped by 100.51% to $29.4 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $29.4 million, $22.5 million, and $14.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.37 Mn |
| Jun 30, 2025 | 22.53 Mn |
| Dec 31, 2024 | 14.65 Mn |
| Dec 31, 2023 | 7.51 Mn |
| Dec 31, 2022 | 6.39 Mn |
| Dec 31, 2021 | 10.29 Mn |
| Sep 30, 2021 | 9.23 Mn |
| Jun 30, 2021 | 9.58 Mn |
| Mar 31, 2021 | 9.40 Mn |
| Dec 31, 2020 | 9.71 Mn |
| Sep 30, 2020 | 10.31 Mn |
| Dec 31, 2019 | 9.91 Mn |
| Sep 30, 2019 | 9.91 Mn |
| Dec 31, 2018 | 10.12 Mn |